Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages

European Journal of Pharmacology
P AkarasereenontJ R Vane

Abstract

Endotoxin causes the expression of inducible nitric oxide (NO) synthase and cyclooxygenase-2. We have compared the ability of endotoxin to increase the activities of these enzymes in bovine aortic endothelial cells and the macrophage cell line (J774.2). Endotoxin (1 microgram ml-1; for 24 h) caused a time-dependent increase in the accumulation of cyclooxygenase metabolites from endogenous arachidonic acid, in both cell types. Cyclooxygenase activity towards exogenous arachidonic acid (30 microM; for 15 min) was also increased in both cell types. Endothelial cells and macrophages also contained comparable amounts of cyclooxygenase-2 protein after incubation with endotoxin for 24 h which was prevented by pretreatment with cycloheximide (10 micrograms ml-1; 30 min prior to endotoxin). Endotoxin for 24 h caused a time-dependent increase in nitrite accumulation in macrophages, but not in endothelial cells. Thus, endotoxin increased cyclooxygenase activity and induced cyclooxygenase-2 protein in endothelial cells and macrophages. Endotoxin also increased NO synthase activity in macrophages, but not in endothelial cells.

References

Mar 1, 1978·Prostaglandins·J A Salmon
Jun 1, 1992·Prostaglandins, Leukotrienes, and Essential Fatty Acids·P V Peplow
May 15, 1992·European Journal of Biochemistry·R Nüsing, V Ullrich
May 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A MantovaniE Dejana
Jun 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K O'BanionD A Young
Oct 1, 1991·The American Journal of Physiology·S LamasP A Marsden
Nov 15, 1990·Biochemical and Biophysical Research Communications·M Di RosaS Moncada
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M W RadomskiS Moncada
Apr 24, 1991·Biochimica Et Biophysica Acta·W L Smith, L J Marnett
Oct 1, 1989·Archives of Dermatology·M Rothe, V Falanga
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G de NucciJ R Vane
Feb 1, 1994·Proceedings of the National Academy of Sciences of the United States of America·I P OswaldS L James
Jan 1, 1994·Advances in Pharmacology·C Thiemermann
Aug 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiP Needleman
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A MitchellJ R Vane
Dec 1, 1993·British Journal of Pharmacology·R S BermanW Martin
Feb 1, 1993·The Journal of Pathology·L PusztaiJ O McGee
Apr 30, 1993·Biochemical and Biophysical Research Communications·C J SmithL J Marnett
Mar 1, 1993·Trends in Pharmacological Sciences·K B GlaserN Senko

❮ Previous
Next ❯

Citations

Jul 27, 2001·Journal of Cellular Physiology·K LelamaliR W Schrier
Apr 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J L BellotA Orts
May 17, 2000·European Journal of Pharmacology·Y TsubouchiM Kondo
Jul 22, 1998·European Journal of Pharmacology·R ZamoraA G Herman
Dec 29, 1998·Toxicology·T MinamiY Okazaki
May 1, 1997·British Journal of Pharmacology·D Bishop-BaileyJ A Mitchell
May 3, 2011·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Ann E AustRonald F Dodson
Dec 16, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·K OsukaJ Yoshida
Jan 1, 1996·Fundamental & Clinical Pharmacology·M Pairet, G Engelhardt
Jan 1, 1996·Fundamental & Clinical Pharmacology·Z Fatehi-HassanabadJ C Stoclet
Jan 1, 1996·Mediators of Inflammation·Y S Bakhle, R M Botting
Mar 4, 2008·American Journal of Veterinary Research·Nicola J Menzies-GowJonathan Elliott
Mar 30, 2012·International Journal of Biological Sciences·Andresa Aparecida BerrettaJuliana Maldonado Marchetti
Apr 26, 2014·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Nicola J Menzies-GowJ Elliott
Nov 7, 2014·Mediators of Inflammation·Sura Wanessa Santos RochaChristina Alves Peixoto
Oct 5, 2010·European Journal of Medicinal Chemistry·Maria IspikoudiKonstantina C Fylaktakidou
Mar 18, 2006·The Journal of Investigative Dermatology·Emiko YoshidaShizuko Kobayashi
Jan 5, 2005·Biochemical and Biophysical Research Communications·Stefan SchildknechtVolker Ullrich
Jan 27, 2005·Pharmacology & Therapeutics·Toshio OhhashiYoshiko Kawai
Nov 29, 2005·Cellular Microbiology·A M SalibaM C Plotkowski
Nov 28, 2006·Phytotherapy Research : PTR·Seok-Jong SuhCheorl-Ho Kim
Jan 5, 2001·Expert Opinion on Investigational Drugs·A T KokiJ L Masferrer
Feb 14, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C WeikD Häussinger
Nov 5, 1997·Arteriosclerosis, Thrombosis, and Vascular Biology·D Bishop-BaileyJ A Mitchell
Oct 9, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D Bishop-BaileyJ A Mitchell
May 6, 2011·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Mette StæhrBoye L Jensen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.